22nd Century Group, Inc. (XXII)

Stock Price: $0.853 USD 0.002 (0.25%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed
GlobeNewsWire - 2 days ago

WILLIAMSVILLE, N.Y., Oct. 22, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, life science company driven by next generation biotechnology, will...

GlobeNewsWire - 5 days ago

The U.S. Food and Drug Administration to provide an update on the Agency's Comprehensive Plan for Tobacco and Nicotine Regulation The U.S. Food and Drug Administration to provide an update on ...

Zacks Investment Research - 1 week ago

22nd Century (XXII) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

GlobeNewsWire - 1 week ago

New intellectual property leads to precise genetic control over nicotine levels in virtually any variety of the tobacco plant New intellectual property leads to precise genetic control over ni...

GlobeNewsWire - 4 weeks ago

WILLIAMSVILLE, N.Y., Sept. 24, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based, life science company driven b...

GlobeNewsWire - 1 month ago

WILLIAMSVILLE, N.Y., Aug. 27, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based life science company driven by ...

Seeking Alpha - 2 months ago

22nd Century Group, Inc. (XXII) CEO Jim Mish on Q2 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

Key Highlights:

Benzinga - 3 months ago

22nd Century Group, Inc. Common Stock Inc (AMEX:XXII) was trading 2.4% higher from the previous closing price.

GlobeNewsWire - 4 months ago

Mish brings extensive global executive leadership experience in the development, manufacturing and commercialization of active pharmaceutical ingredients, including cannabinoids, and related c...

Seeking Alpha - 5 months ago

22nd Century Group, Inc. (XXII) Q1 2020 Results - Earnings Call Transcript

GlobeNewsWire - 6 months ago

22nd Century Group achieves another important milestone in the FDA’s scientific review of the Company’s MRTP application for its reduced nicotine content cigarettes 22nd Century Group achieves...

GlobeNewsWire - 6 months ago

Williamsville, NY, April 08, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduc...

GlobeNewsWire - 7 months ago

Delivers Complete High-Quality Hemp/Cannabis Genome Sequence; Establishes New Proprietary Hemp/Cannabis Bioinformatics Platform

GlobeNewsWire - 7 months ago

New Vice President of Acquisitions and New Director of Communications & Investor Relations Set to Drive Acquisition Efforts and Improve Investor Engagement New Vice President of Acquisitions a...

GlobeNewsWire - 7 months ago

Congressman Pallone Urges FDA to Move Forward with Proposal to Limit Nicotine in All Cigarettes Congressman Pallone Urges FDA to Move Forward with Proposal to Limit Nicotine in All Cigarettes

GlobeNewsWire - 7 months ago

Congressman Pallone Urges FDA to Move Forward with Proposal to Limit Nicotine in All Cigarettes Congressman Pallone Urges FDA to Move Forward with Proposal to Limit Nicotine in All Cigarettes

GlobeNewsWire - 9 months ago

Williamsville, NY, Jan. 13, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicoti...

GlobeNewsWire - 10 months ago

Meeting is next official step toward possible marketing authorization for 22nd Century Group’s VLN® product in the United States Meeting is next official step toward possible marketing authori...

GlobeNewsWire - 10 months ago

FDA determines that sale of product in the U.S. is ‘appropriate for the protection of the public health’ FDA determines that sale of product in the U.S. is ‘appropriate for the protection of t...

GlobeNewsWire - 10 months ago

Williamsville, NY, Dec. 13, 2019 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicoti...

Benzinga - 10 months ago

22nd Century Group Inc (NYSE: XXII) a plant biotechnology company focused on tobacco and cannabis plant research, on Wednesday announced the initial closing of an investment in Panacea Life Sc...

GlobeNewsWire - 10 months ago

Investment provides platform to commercialize 22nd Century’s unique hemp/cannabis plant lines in development and leverage strengths in consumer-packaged-goods and FDA-regulatory affairs Invest...

The Motley Fool - 11 months ago

Which stock wins in a matchup between these two cannabis-focused biotechs?

Other stocks mentioned: GWPH
The Motley Fool - 1 year ago

Put in another context, these are the only six pot stocks that rose last month.

Other stocks mentioned: ACRGF, CGC, IIPR, NXTTF, STZ, STZ.B, TCNNF
The Motley Fool - 1 year ago

Last month was a rough one for most pot stocks. But these three managed to deliver gains despite the overall malaise.

Other stocks mentioned: IIPR, NXTTF
The Motley Fool - 1 year ago

Despite another miserable month for marijuana stocks, these companies managed to buck the trend.

Other stocks mentioned: APHA, CBWTF, CRLBF, ORHOF, SHOP, STZ, TGODF, TRSSF, ZYNE
The Motley Fool - 1 year ago

Most pot stocks performed poorly last month, but not these three highfliers.

Other stocks mentioned: APHA, TGODF
GuruFocus - 1 year ago

President and CEO of 22nd Century Group Inc (30-Year Financial, Insider Trades) Clifford B Fleet (insider trades) bought 100,000 shares of XXII on 08/27/2019 at an average price of $1.9 a share.

Zacks Investment Research - 1 year ago

As of late, it has definitely been a great time to be an investor 22nd Century Group.

Seeking Alpha - 1 year ago

22nd Century Group's tobacco business still looks like a big ball of problems.

Seeking Alpha - 1 year ago

22nd Century Group, Inc. (XXII) CEO Cliff Fleet on Q2 2019 Results - Earnings Call Transcript

The Motley Fool - 1 year ago

There aren't a huge number of U.S.-listed stocks with a tobacco focus, but these companies still combine to be a force in the global industry.

Other stocks mentioned: BTI, MO, PM, TPB, UVV, VGR
The Motley Fool - 1 year ago

Only around 1 in 4 marijuana stocks ended the second quarter higher.

Other stocks mentioned: FLWPF, GWPH, HMMJ, IIPR, MEDIF, MLCPF, PLNHF, SMG, VGWCF
The Motley Fool - 1 year ago

The grass may not be greener with these particular pot stocks.

Other stocks mentioned: CGC, SVVTF
The Motley Fool - 1 year ago

Despite a rare down month for pot stocks as a whole, these 10 companies finished April higher by at least 15%.

Other stocks mentioned: CGC, CRLBF, HEXO, PLNHF, STZ, STZ.B
The Motley Fool - 1 year ago

These pot stocks soared last month, and two still look like great picks for investors.

Other stocks mentioned: CGC, HEXO, NEPT, STZ
The Motley Fool - 1 year ago

The green rush went up in smoke for shareholders in these five marijuana stocks.

The Motley Fool - 1 year ago

There are some very familiar marijuana stocks among this bunch of losers.

Other stocks mentioned: ALEAF, INSY
CNBC Television - 1 year ago

Video: Hollywood embraces the cannabis craze

The red carpet is getting a little bit greener as Hollywood embraces cannabis. Will more green appear on the silver screen? With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Bri...

Other stocks mentioned: CGC, CRON, GWPH, MJ, SMG, TLRY, VGR, ACB
CNBC Television - 1 year ago

Video: Has the cannabis craze now become tulip mania 2.0?

Raymond James' Dave Novak on whether the pot trade is all smoke and mirrors? With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Brian Kelly, Dan Nathan and Guy Adami.

Other stocks mentioned: CARA, CGC, CRON, GWPH, IGC, IIPR, MJ, MO, SMG, TLRY, VGR, ACB
Yahoo Finance - 1 year ago

Video: Cannabis industry trends and concerns

The National Cannabis Industry Association Conference starts today in Boston. Yahoo Finance discusses what the growth drivers of the cannabis industry are.

Other stocks mentioned: CARA, CGC, CRON, GWPH, IIPR, INSY, MJ, SMG, TLRY, VGR, ZYNE
Yahoo Finance - 1 year ago

Video: The science of cannabis

CBD is used in medicines, supplements, foods and beauty products but it is different from THC.

Other stocks mentioned: CARA, CGC, CRON, GWPH, IIPR, INSY, MJ, TLRY, VGR, ZYNE, SMG
Yahoo Finance - 1 year ago

Video: CDC blames vaping for increase in teen tobacco use

Twenty-one percent of teens surveyed use e-cigarettes.

Other stocks mentioned: BTI, MO, PM, VGR
CNBC Television - 1 year ago

Video: CDC Report: Tobacco use among teens increased 36 percent in 2018

CNBC's Aditi Roy reports on a new CDC report showing tobacco use among teens is rising, driven by e-cigarettes.

Other stocks mentioned: BTI, MO, PM, VGR
CNBC International TV - 1 year ago

Video: Cannabis is the new tech, says former Yahoo CEO

Former Yahoo CEO Carol Bartz discusses her investment in cannabis through Caliva on CNBC's "Squawk Alley".

Other stocks mentioned: CGC, CRON, GWPH, TLRY, ABBV, CARA, IGC, IIPR, INSY, MJ, MO, PM, SMG, SWM, UVV, VGR, ZYNE

Latest From StockTwits